首页> 外文期刊>Pathology International >Comedonecrosis is an unfavorable marker in node-negative invasive breast carcinoma.
【24h】

Comedonecrosis is an unfavorable marker in node-negative invasive breast carcinoma.

机译:粉刺坏死是淋巴结阴性浸润性乳腺癌的不利标志。

获取原文
获取原文并翻译 | 示例
           

摘要

Breast carcinoma is usually accompanied by an invasive component with an intraductal component, and each component shows different morphological features. We evaluated whether the presence or absence of comedonecrosis is correlated with prognosis and biological features in node-negative invasive breast carcinoma. Ninety-four node-negative breast carcinomas with an intraductal component were classified into two types: comedo type (n = 36) showing comedonecrosis partly or extensively in the intraductal component, and non-comedo type (n = 58) showing either an absence or small foci of necrosis. The Kaplan-Meier method was used to calculate disease-free survival. Immunohistochemical examination for p53 and HER-2 was conducted on the comedo (n = 35) and non-comedo (n = 47) type tumor specimens. Disease-free survival was significantly shorter in the comedo type than in the non-comedo type (P = 0.019). The expression of p53 was observed in 16 (45.7%) of the 35 comedo type cases, but only in two (4.3%) of the 47 non-comedo type cases (P < 0.0001). HER-2 overexpression was observed in seven (20.0%) of the 35 comedo type cases, while none of the 47 non-comedo type cases overexpressed HER-2 (P < 0.0001). These results suggest that the presence of comedonecrosis may be predictive of an unfavorable prognosis with aggressive biological behavior in node-negative invasive breast carcinoma.
机译:乳腺癌通常伴有具有导管内成分的浸润性成分,并且每种成分均表现出不同的形态学特征。我们评估了粉刺坏死的存在与否与淋巴结阴性浸润性乳腺癌的预后和生物学特征有关。 94例具有导管内成分的淋巴结阴性乳腺癌被分为两种类型:粉刺类型(n = 36),在导管内成分中部分或广泛显示粉刺坏死;和非粉刺类型(n = 58),其显示缺失或部分。小坏死灶。 Kaplan-Meier方法用于计算无病生存期。 p53和HER-2的免疫组织化学检查是在粉刺(n = 35)和非粉刺(n = 47)型肿瘤标本上进行的。在粉刺类型中,无病生存期明显短于非粉刺类型(P = 0.019)。 35例粉刺型病例中有16例(45.7%)观察到p53的表达,但47例非粉刺型病例中只有2例(4.3%)观察到(P <0.0001)。 35例粉刺型病例中有7例(20.0%)观察到HER-2过表达,而47例非粉刺型病例中均未发现HER-2过表达(P <0.0001)。这些结果表明粉刺坏死的存在可能预示着淋巴结阴性浸润性乳腺癌中侵袭性生物学行为的不良预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号